← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2011Last known activity
Jun 1, 2020
Timeline
1990s
- Jan 1, 1993
Al-Neelain University— Founded
Drugs by trial phase (5 distinct, 8 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT04381871Reponsible party - principal investigatorPhase 2/Phase 3Jun 1, 2020
- NCT04381871Study chairPhase 2/Phase 3Jun 1, 2020
- NCT04381871Lead sponsorPhase 2/Phase 3Jun 1, 2020
- NCT04215380Sponsor investigatorPhase 2/Phase 3Jan 5, 2020
- NCT04215380Lead sponsorPhase 2/Phase 3Jan 5, 2020
- NCT04215380Study directorPhase 2/Phase 3Jan 5, 2020
- NCT04191213Study directorPhase 2/Phase 3Dec 15, 2019
- NCT04191213Reponsible party - principal investigatorPhase 2/Phase 3Dec 15, 2019
- NCT04191213Lead sponsorPhase 2/Phase 3Dec 15, 2019
- NCT03214692Lead sponsorN/AJul 31, 2017
- NCT03214692Sponsor investigatorN/AJul 31, 2017
- NCT02804581Lead sponsorPhase 2Jun 1, 2016
- NCT02804581Sponsor investigatorPhase 2Jun 1, 2016
- NCT02467257Lead sponsorPhase 1/Phase 2Apr 1, 2014
- NCT02467257Reponsible party - principal investigatorPhase 1/Phase 2Apr 1, 2014
Details
- Founded
- Khartoum, SD Jan 1, 1993
- Last known activity
- Jun 1, 2020